Skip to main content

Ranitidine Products Removed From Formulary April 2, 2020

Last updated on 5/18/2020

On April 1, 2020, the Federal Drug Administration (FDA) requested that manufacturers withdraw all ranitidine products (commonly known by the brand name Zantac) from the market because of consumer exposure to unacceptable levels of impurities.

Ranitidine products were removed from the Medicaid and CHIP formularies on April 2, 2020. Formulary alternatives available include famotidine (10mg, 20mg and 40 mg), cimetidine (200mg, 300mg, 400mg, and 800mg), and nizatidine (150mg and 300mg).

A list of the removed drugs is available online. Contact vdp-formulary@hhsc.state.tx.us for questions or more information.